ATF3 recruits LXRs to AP-1 motif-containing enhancers, enabling the activation of genes such as Trem2 and Cd9, suggesting their role in shaping SAM and LAM phenotypes [40]. The gene discussed is TREM2; the disease is lymphangioleiomyomatosis.